The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.

The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.

Item
http://www.wikidata.org/entity/Q45754566
The evolution of poxvirus vaccinesModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesReplication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.Multivalent and Multipathogen Viral Vector Vaccines.Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodesLong-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.
P2860

The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.

Item
http://www.wikidata.org/entity/Q45754566
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@en
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@nl
type
label
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@en
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@nl
prefLabel
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@en
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
The immunogenicity and efficac ...... ecombinants in rhesus monkeys.
@en
P2093
P304
P31
P356
10.1016/S0264-410X(98)00010-3
P407
P433
P478
P577
P698